Concepedia

Publication | Open Access

Monocarboxylate Transporter 1 (MCT1) is an independent prognostic biomarker in endometrial cancer

DOIFull Paper Access

47

Citations

38

References

2017

Year

Ayşe Latif, Amy L. Chadwick, Sarah Kitson, Hannah J. Gregson, Vanitha N. Sivalingam, James M. Bolton, Rhona J. McVey, Stephen A. Roberts, Kay Marshall, Kaye J. Williams,
BMC Clinical Pathology

Abstract

Our data suggest that MCT1 expression is an important marker of poor prognosis in EC. MCT1 inhibition may have potential as a treatment for advanced or recurrent EC.

References

YearCitations

Page 1